Enantioselective catalysis is of crucial importance in modern chemistry and pharmaceutical science. To obtain high purity chiral compounds, although various concepts have been used for the development of enantioselective catalysts, most of them are based on homogeneous catalytic systems. Recently, we have successfully developed nanostructured metal layers imprinted with chiral information, which have been applied as electrocatalysts for the enantioselective synthesis of chiral model compounds. However, so far such materials have not been employed as heterogeneous catalysts for the enantioselective synthesis of real pharmaceutical products. In this contribution, we report the asymmetric synthesis of chiral pharmaceuticals (CPs) with chiral imprinted Pt‐Ir surfaces as a simple hydrogenation catalyst. By fine‐tuning the experimental parameters, a very high enantioselectivity (up to 95% enantiomeric excess, ee) with good catalyst stability can be achieved. The designed materials have also been successfully used as catalytically active stationary phases for the continuous asymmetric flow synthesis of pharmaceutical compounds. This illustrates the possibility of producing for the first time real chiral pharmaceuticals at such nanostructured metal surfaces.